Literature DB >> 34236330

Is the increase in eltrombopag dose cause of myocardial infarction?

Edip Can Özgünoğlu1, Nermin Bayar1, Şakir Arslan1, Muhammed Rıdvan Ersoysal1, Rauf Avcı1.   

Abstract

Entities:  

Year:  2021        PMID： 34236330      PMCID： PMC8274900          DOI： 10.5152/AnatolJCardiol.2021.45605

Source DB:  PubMed          Journal:  Anatol J Cardiol        ISSN： 2149-2263            Impact factor:   1.596


× No keyword cloud information.
  9 in total

1.  Successful thrombolytic therapy for ST-elevation acute myocardial infarction in a patient with immune thrombocytopenic purpura.

Authors:  Erkan Koklu; Gorkem Kus; Isa Oner Yuksel; Selcuk Kucukseymen; Sakir Arslan
Journal:  Am J Emerg Med       Date:  2015-06-19       Impact factor: 2.469

Review 2.  The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia.

Authors:  Cindy Neunert; Wendy Lim; Mark Crowther; Alan Cohen; Lawrence Solberg; Mark A Crowther
Journal:  Blood       Date:  2011-02-16       Impact factor: 22.113

3.  Function of eltrombopag-induced platelets compared to platelets from control patients with immune thrombocytopenia.

Authors:  Johanna Haselboeck; Alexandra Kaider; Ingrid Pabinger; Simon Panzer
Journal:  Thromb Haemost       Date:  2013-02-07       Impact factor: 5.249

4.  Drug-induced immune thrombocytopaenia: results from the Berlin Case-Control Surveillance Study.

Authors:  Edeltraut Garbe; Frank Andersohn; Elisabeth Bronder; Abdulgabar Salama; Andreas Klimpel; Michael Thomae; Hubert Schrezenmeier; Martin Hildebrandt; Ernst Späth-Schwalbe; Andreas Grüneisen; Oliver Meyer; Hanife Kurtal
Journal:  Eur J Clin Pharmacol       Date:  2011-12-21       Impact factor: 2.953

5.  Recurrent Coronary Thrombus in a Patient with Chronic Immune Thrombocytopenia with Treatment Using Eltrombopag.

Authors:  Terumori Satoh; Masao Saotome; Kenichiro Suwa; Hayato Ohtani; Yasuyuki Nagata; Takaaki Ono; Yuichiro Maekawa
Journal:  Case Rep Cardiol       Date:  2019-03-26

6.  Cardiac and pulmonary thrombosis during multidrug treatment in an idiopathic thrombocytopenic purpura patient.

Authors:  Neslihan Andic; Eren Gunduz; Olga Meltem Akay; Deniz Şahin; Hava Üsküdar Teke
Journal:  Platelets       Date:  2013-01-15       Impact factor: 3.862

7.  Eltrombopag Induced Thrombosis: A Case with Acute Myocardial Infarction.

Authors:  Hakan Gunes; Tarik Kivrak
Journal:  Curr Drug Saf       Date:  2016

8.  A sticky situation: myocardial infarction in a young woman with immune thrombocytopenia on eltrombopag and a history of mediastinal radiation.

Authors:  Jennifer Teichman; Ahmed Taher; Abdulaziz Hashi; Akshay Bagai; Michelle Sholzberg
Journal:  J Thromb Thrombolysis       Date:  2018-01       Impact factor: 2.300

9.  Acute Myocardial Infarction Due to Eltrombopag Therapy in a Patient with Immune Thrombocytopenic Purpura.

Authors:  Sena Sert; Hasan Özdil; Murat Sünbül
Journal:  Turk J Haematol       Date:  2016-12-12       Impact factor: 1.831
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.